Results 101 to 110 of about 143,581 (292)

Concurrence of pleural effusion and inferior vena cava thrombus in antiphospholipid syndrome complicated by intra-cardiac thrombus

open access: yesResearch in Cardiovascular Medicine, 2016
Introduction: Antiphospholipid syndrome (APS) associated with intra-cardiac thrombus and pulmonary embolism is infrequent. However, the presence of pleural effusion is extremely rare.
Amin Bagheri, Jamshid Bagheri
doaj   +1 more source

Implementation of OMOP and ConcePTION Common Data Models in CPRD GOLD: Risk of Bleeding and Cardiovascular Outcomes From Anticoagulant Use

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
The impact of the choice of common data model (CDM) approach on the study results in a real‐world evidence (RWE) study is unknown. We aimed to determine potential differences in the results of an RWE study when data were mapped to two different CDMs, ConcePTION and OMOP. With the same instance of CPRD GOLD, data were mapped to both CDMs. Using the same
Nicholas B. Hunt   +8 more
wiley   +1 more source

INFERIOR VENA CAVA SUPRARENAL FILTER IMPLANTATION

open access: yesВестник рентгенологии и радиологии, 2017
The paper analyzes indications for, frequency, safety, and efficiency of inferior vena cava (IVC) suprarenal filter implantation. The study based on the Medline database has indicated that an IVC suprarenal filter should be implanted following very ...
S. A. Prozorov
doaj   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia   +2 more
wiley   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo   +7 more
wiley   +1 more source

Circulatory contributors to the phenotype in hereditary hemorrhagic telangiectasia [PDF]

open access: yes, 2015
Hereditary hemorrhagic telangiectasia (HHT) is mechanistically and therapeutically challenging, not only because of the molecular and cellular perturbations that generate vascular abnormalities, but also the modifications to circulatory physiology that ...
Shovlin, CL
core   +2 more sources

Cardiovascular toxicity induced by TKIs in patients with chronic myeloid leukaemia: Are women and men different?

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1447-1454, April 2025.
This study analyzes 148 patients (66 women and 82 men) with chronic myeloid leukemia treated with tyrosine kinase inhibitors, focusing on cardiovascular adverse events. The risk assessment, performed using the HFA/ICOS score, reveals sex‐specific differences: venous thrombosis is more common in women, while arterial thrombosis predominates in men.
Cristina Madaudo   +10 more
wiley   +1 more source

Nutritional Potential, Phytochemical Content, In Vivo Antioxidant, and Antanemic Potential of Musa paradisiaca Flower

open access: yesFood Chemistry International, EarlyView.
After collecting Musa paradisiaca leaves, some were dried and others were used to produce aqueous extracts. The extracts and powders were characterized and then administered to rats made anaemic by PHZ. After 14 days of administration of the two samples, the rats were euthanized and it was observed that after 9 days of treatment, the aqueous extract ...
Josée Rebeca Nombo   +8 more
wiley   +1 more source

PULMONARY VEIN THROMBOSIS: IT’S NOT ALWAYS PULMONARY EMBOLISM

open access: yesJournal of the American College of Cardiology, 2016
Pulmonary vein thrombosis is a rarely encountered disease entity that can have several different clinical presentations. It is usually associated with lung surgeries, lung carcinoma, mitral stenosis or as a complication of the radiofrequency catheter ablation procedure.
openaire   +1 more source

Idiopathic Pulmonary Vein Thrombosis, Case Report

open access: yes, 2022
Pulmonary vein thrombosis is a rare entity, however it requires high clinical suspicion to be diagnosed due to lack of specific symptoms. Clinical presentation ranges from silent event and incidental finding to fatal event and end organ damage. Early diagnosis is essential to prevent systemic complications.
openaire   +1 more source

Home - About - Disclaimer - Privacy